These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8418225

  • 21. Octreotide in the management of diarrhea induced by graft versus host disease.
    Ippoliti C, Neumann J.
    Oncol Nurs Forum; 1998 Jun; 25(5):873-8. PubMed ID: 9644703
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of the efficacy of octreotide LAR in the treatment of Crohn's disease associated refractory diarrhea.
    Martelli L, Colard A, Fontaine F, Deflandre J, Bastens B, Louis E.
    Scand J Gastroenterol; 2017 May; 52(5):564-569. PubMed ID: 28270045
    [Abstract] [Full Text] [Related]

  • 23. Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.
    Köhne CH, Schöffski P, Wilke H, Käufer C, Andreesen R, Ohl U, Klaasen U, Westerhausen M, Hiddemann W, Schott G, Harstick A, Bade J, Horster A, Schubert U, Hecker H, Dörken B, Schmoll HJ.
    J Clin Oncol; 1998 Feb; 16(2):418-26. PubMed ID: 9469324
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma.
    Gennatas C, Papaxoinis G, Michalaki V, Mouratidou D, Andreadis C, Tsavaris N, Pafiti A.
    J Chemother; 2006 Oct; 18(5):538-44. PubMed ID: 17127232
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.
    Ippoliti C, Champlin R, Bugazia N, Przepiorka D, Neumann J, Giralt S, Khouri I, Gajewski J.
    J Clin Oncol; 1997 Nov; 15(11):3350-4. PubMed ID: 9363865
    [Abstract] [Full Text] [Related]

  • 29. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.
    Rothenberg ML, Eckardt JR, Kuhn JG, Burris HA, Nelson J, Hilsenbeck SG, Rodriguez GI, Thurman AM, Smith LS, Eckhardt SG, Weiss GR, Elfring GL, Rinaldi DA, Schaaf LJ, Von Hoff DD.
    J Clin Oncol; 1996 Apr; 14(4):1128-35. PubMed ID: 8648367
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of diarrhea with loperamide in palliative medicine. A systematic review].
    Pastrana T, Meißner W.
    Schmerz; 2013 Apr; 27(2):182-9. PubMed ID: 23475156
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy.
    Wasserman E, Hidalgo M, Hornedo J, Cortés-Funes H.
    Bone Marrow Transplant; 1997 Nov; 20(9):711-4. PubMed ID: 9384471
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A comparative study of racecadotril and single dose octreotide as an anti-secretory agent in acute infective diarrhoea.
    Mehta S, Khandelwal PD, Jain VK, Sihag M.
    J Assoc Physicians India; 2012 Nov; 60():12-5. PubMed ID: 23767196
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic response to octreotide in patients with refractory CPT-11 induced diarrhea.
    Pro B, Lozano R, Ajani JA.
    Invest New Drugs; 2001 Nov; 19(4):341-3. PubMed ID: 11561696
    [Abstract] [Full Text] [Related]

  • 39. Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
    Burch PA, Block M, Schroeder G, Kugler JW, Sargent DJ, Braich TA, Mailliard JA, Michalak JC, Hatfield AK, Wright K, Kuross SA.
    Clin Cancer Res; 2000 Sep; 6(9):3486-92. PubMed ID: 10999733
    [Abstract] [Full Text] [Related]

  • 40. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial.
    Cello JP, Grendell JH, Basuk P, Simon D, Weiss L, Wittner M, Rood RP, Wilcox CM, Forsmark CE, Read AE.
    Ann Intern Med; 1991 Nov 01; 115(9):705-10. PubMed ID: 1929038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.